Sign up to save your podcasts
Or
Share Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice
Did you know androgen deprivation monotherapy is no longer considered standard of care for metastatic hormone-sensitive prostate cancer (mHSPC) by experts?
Credit available for this activity expires: 11/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001957?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2525 ratings
Did you know androgen deprivation monotherapy is no longer considered standard of care for metastatic hormone-sensitive prostate cancer (mHSPC) by experts?
Credit available for this activity expires: 11/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001957?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
134 Listeners
AFP: American Family Physician Podcast
696 Listeners
JAMA Clinical Reviews
501 Listeners
JACC This Week
166 Listeners
Diabetes Core Update
106 Listeners
This Week in Cardiology
886 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
301 Listeners
Frankly Speaking About Family Medicine
264 Listeners
The Curbsiders Internal Medicine Podcast
3,364 Listeners
Core IM | Internal Medicine Podcast
1,141 Listeners
Annals On Call Podcast
197 Listeners
JAMA Medical News
91 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Freely Filtered, a NephJC Podcast
169 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
9 Listeners
Cardionerds: A Cardiology Podcast
424 Listeners